mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.7 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |